Developing optimized drug formulations is time‑consuming, requires extensive experimental work, and often consumes large amounts of material, slowing the delivery of new medicines to patients.

Intrepid Labs offers VALIANT, a modular autonomous laboratory that integrates active machine learning with advanced robotics to plan, execute, and analyze formulation experiments. The platform uses data‑driven experiment planning to select formulation compositions, then robotic equipment prepares and characterizes multiple candidates in parallel. By employing active learning, VALIANT reduces the number of experiments and the amount of drug material needed to identify optimal formulations. The closed‑loop workflow continuously updates predictive models with new data, accelerating the convergence on lead candidates across a wide range of dosage forms. This approach enables pharmaceutical developers to generate fully optimized formulations faster and at lower cost, improving the overall efficiency of drug product development.

AI‑driven experiment planning that selects formulation compositions using active learning

Fully automated robotic workcells for parallel preparation and high‑throughput characterization of formulations

Closed‑loop data integration that continuously refines predictive ML models with each experiment

Capability to handle diverse formulation types, including injectables, solid dosage forms, and nanoparticle suspensions

Scalable throughput from tens to hundreds of unique formulations per day with minimal sample material

Modular hardware architecture allowing reconfiguration for custom workflow requirements

Primary customers are pharmaceutical companies and biotech firms that need rapid, data‑centric development of optimized drug formulations for new chemical entities and existing pipelines.